Exelixis Inc

EXEL

Market Cap$6.44B

Close$

Compare Exelixis

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Exelixis Inc	31.4	0%	10%	3.5	-
Market Avg	53.2	1.27%	29%	-	1.3
Healthcare Avg	29.7	1.32%	16%	7.3	1.3

$25.00

Target Price by Analysts

19.6% upsideExelixis Target Price Details

$56.38

Current Fair Value

169.6% upside

Undervalued by 169.6% based on the discounted cash flow analysis.

Share Statistics

Market cap	$6.44 Billion
Enterprise Value	$5.47 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$0.65
Beta	0.2
Outstanding Shares	303,200,000
Avg 30 Day Volume	2,286,894

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	31.39
PEG	-463.5
Price to Sales	3.49
Price to Book Ratio	2.99
Enterprise Value to Revenue	2.96
Enterprise Value to EBIT	26.79
Enterprise Value to Net Income	26
Total Debt to Enterprise	0
Debt to Equity	0

Revenue Sources

No data

ESG Score

No data

About Exelixis Inc